Tata Chemicals (TATACHEM)₹604.75−0.58%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Tata Chemicals reported sales of ₹4,244 Cr, up 14.3% from Jun 2025, and net profit of ₹59.84 Cr, down 81.0% year on year. For the year to Mar 2026, sales were ₹14,563 Cr and net profit −₹1,710 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,991 | 3,724 | 3,470 | 3,780 | 3,989 | 3,585 | 3,503 | 3,713 | 3,871 | 3,543 | 3,433 | 4,244 |
| Expenses | 3,185 | 3,184 | 3,030 | 3,209 | 3,378 | 3,150 | 3,179 | 3,065 | 3,337 | 3,200 | 3,157 | 3,709 |
| Operating Profit | 808 | 543 | 444 | 574 | 618 | 434 | 327 | 649 | 538 | 345 | 274 | 538 |
| OPM % | 20.0% | 15.0% | 12.9% | 14.9% | 14.9% | 11.9% | 9.0% | 16.9% | 13.9% | 9.9% | 7.9% | 12.9% |
| Other Income | 188 | 98.35 | −864 | 116 | 153 | −10.04 | 29.10 | 139 | 129 | 21.06 | −1,767 | 56.23 |
| Interest | 146 | 133 | 131 | 134 | 146 | 149 | 138 | 148 | 145 | 147 | 154 | 149 |
| Depreciation | 235 | 247 | 272 | 274 | 278 | 281 | 294 | 281 | 286 | 294 | 345 | 337 |
| Profit before tax | 615 | 262 | −819 | 284 | 348 | −3.99 | −74.05 | 360 | 236 | −73.01 | −1,982 | 110 |
| Tax % | 20.0% | 26.0% | 3.0% | 33.0% | 23.0% | 425.0% | −34.0% | 12.0% | 35.1% | −5.0% | 7.0% | 45.0% |
| Exceptional items | 82.01 | 0.00 | −965 | 14.99 | 0.00 | −53.01 | −32.04 | 0.00 | −41.99 | −39.03 | −1,713 | 0.00 |
| Net Profit | 494 | 194 | −839 | 190 | 266 | −20.96 | −48.85 | 315 | 154 | −68.81 | −2,110 | 59.84 |
| EPS (Rs) | 16.82 | 6.21 | −33.44 | 5.90 | 7.62 | −2.09 | −2.21 | 9.91 | 3.03 | −3.66 | −83.86 | −0.68 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14,853 | 10,326 | 10,249 | 10,313 | 10,332 | 10,179 | 12,591 | 16,760 | 15,400 | 14,861 | 14,563 | 15,091 |
| Expenses | 12,757 | 8,240 | 6,919 | 8,525 | 8,403 | 8,686 | 10,282 | 12,942 | 12,567 | 12,921 | 12,752 | 13,404 |
| Operating Profit | 2,097 | 2,099 | 3,345 | 1,801 | 1,947 | 1,507 | 2,321 | 3,821 | 2,851 | 1,953 | 1,807 | 1,696 |
| OPM % | 13.9% | 20.0% | 33.0% | 16.9% | 19.0% | 15.0% | 17.9% | 22.9% | 17.9% | 13.0% | 11.9% | 11.2% |
| Other Income | 211 | 294 | 263 | 787 | 6,503 | 255 | 473 | 219 | −509 | 288 | −1,479 | −1,561 |
| Interest | 527 | 298 | 327 | 355 | 344 | 368 | 304 | 408 | 532 | 565 | 593 | 593 |
| Depreciation | 528 | 514 | 520 | 570 | 668 | 762 | 809 | 895 | 984 | 1,127 | 1,206 | 1,261 |
| Profit before tax | 1,254 | 1,580 | 2,764 | 1,661 | 7,415 | 635 | 1,683 | 2,741 | 830 | 554 | −1,459 | −1,709 |
| Tax % | 20.1% | 22.0% | 2.0% | 17.1% | 3.0% | 31.0% | 16.0% | 11.0% | 46.0% | 30.1% | 18.1% | — |
| Exceptional items | −3.01 | 0.00 | 94.04 | 195 | 139 | 36.03 | 27.02 | 48.04 | −356 | −46.06 | −2,167 | −1,794 |
| Net Profit | 1,003 | 1,230 | 2,697 | 1,384 | 7,206 | 435 | 1,402 | 2,428 | 434 | 386 | −1,710 | −1,966 |
| EPS (Rs) | 30.28 | 39.01 | 95.66 | 45.42 | 275.42 | 10.08 | 49.43 | 91.12 | 10.54 | 9.23 | −74.58 | −85.17 |
| Dividend payout % | 32.9% | 28.0% | 23.0% | 28.0% | 4.0% | 99.0% | 24.9% | 19.0% | 143.0% | 119.0% | −15.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 254 | 254 | 255 | 254 | 254 | 254 | 254 | 254 | 254 | 254 | 255 | 254 |
| Reserves | 5,281 | 6,581 | 7,643 | 10,824 | 12,058 | 12,612 | 14,010 | 17,959 | 19,438 | 21,928 | 21,284 | 20,911 |
| Borrowings | 8,381 | 9,105 | 7,089 | 6,123 | 6,149 | 7,722 | 6,951 | 7,038 | 6,310 | 5,576 | 7,087 | 8,020 |
| Other Liabilities | 6,839 | 8,362 | 8,570 | 8,622 | 8,381 | 7,051 | 7,090 | 8,585 | 8,926 | 8,934 | 9,099 | 9,783 |
| Total Liabilities | 20,754 | 24,301 | 23,556 | 25,823 | 26,842 | 27,640 | 28,305 | 33,836 | 34,928 | 36,692 | 37,724 | 38,968 |
| Fixed Assets | 11,321 | 13,384 | 12,616 | 12,756 | 13,518 | 15,312 | 15,209 | 16,009 | 17,057 | 17,809 | 19,553 | 20,551 |
| CWIP | 190 | 351 | 334 | 410 | 776 | 837 | 1,097 | 1,673 | 2,416 | 2,222 | 1,918 | 1,040 |
| Investments | 444 | 2,193 | 2,795 | 2,846 | 5,630 | 4,299 | 5,837 | 7,709 | 7,466 | 9,769 | 9,164 | 9,909 |
| Other Assets | 8,799 | 8,373 | 7,811 | 9,810 | 6,918 | 7,193 | 6,163 | 8,446 | 7,989 | 6,891 | 7,089 | 7,467 |
| Inventories | 2,624 | 1,930 | 1,384 | 1,461 | 1,723 | 1,866 | 1,684 | 2,290 | 2,529 | 2,519 | 2,556 | 3,079 |
| Trade receivables | 3,428 | 3,565 | 2,092 | 1,308 | 1,452 | 1,581 | 1,397 | 1,934 | 2,626 | 1,899 | 1,901 | 2,089 |
| Cash & equivalents | 1,461 | 1,264 | 1,664 | 4,474 | 1,949 | 2,077 | 1,408 | 1,309 | 664 | 645 | 614 | 442 |
| Total Assets | 20,754 | 24,301 | 23,556 | 25,823 | 26,842 | 27,640 | 28,305 | 33,836 | 34,928 | 36,692 | 37,724 | 38,968 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1,270 | 2,324 | 3,515 | 1,862 | 1,575 | 1,773 | 2,029 | 1,638 | 2,961 | 3,004 | 1,753 | 1,264 |
| Cash from investing activity | −665 | −464 | −988 | 2,721 | −1,934 | −2,293 | −1,151 | −819 | −1,153 | −606 | −1,673 | −768 |
| Cash from financing activity | −1,089 | −1,804 | −2,343 | −2,091 | −1,713 | −129 | −1,458 | −756 | −2,077 | −2,497 | 29.01 | −670 |
| Net cash flow | −476 | 67.89 | 205 | 2,491 | −2,056 | −633 | −565 | 71.90 | −254 | −82.86 | 123 | −167 |
| Capex | 607 | 691 | 646 | 751 | 1,083 | 1,200 | 1,243 | 1,278 | 1,580 | 1,836 | 2,009 | 1,206 |
| Free cash flow | 712 | 1,652 | 2,901 | 1,145 | 504 | 613 | 807 | 381 | 1,432 | 1,198 | −192 | 130 |
| CFO / OP % | 86.0% | 128.9% | 190.0% | 70.9% | 114.9% | 98.9% | 141.9% | 81.9% | 88.0% | 119.9% | 102.0% | 66.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 74 | 89 | 75 | 47 | 52 | 57 | 51 | 57 | 58 | 46 | 48 | 53 |
| Inventory days | 136 | 118 | 243 | 303 | 314 | 346 | 256 | 316 | 281 | 340 | 323 | 352 |
| Days payable | 137 | 98 | 231 | 306 | 268 | 301 | 255 | 337 | 288 | 319 | 317 | 292 |
| Cash conversion cycle | 72 | 107 | 86 | 43 | 97 | 100 | 51 | 35 | 50 | 66 | 53 | 113 |
| Working capital days | −4 | 31 | −4 | 27 | −2 | −102 | −28 | −29 | 29 | −22 | −21 | −17 |
| ROCE % | 11.0% | 11.0% | 10.0% | 16.0% | 9.0% | 36.0% | 4.0% | 8.0% | 12.0% | 8.0% | 4.0% | 3.0% |
For the Jun 2026 quarter, Tata Chemicals reported sales of ₹4,244 Cr, up 14.3% year on year and net profit of ₹59.84 Cr, down 81.0% year on year. The operating margin was 12.9%.
Tata Chemicals' sales for the year to Mar 2026 were ₹14,563 Cr; over the last twelve months they were ₹15,091 Cr.
Net profit for the year to Mar 2026 was −₹1,710 Cr, and −₹1,966 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−85.17.
Tata Chemicals reported borrowings of ₹8,020 Cr at Mar 2026, against cash and equivalents of ₹442 Cr.
Cash from operations was ₹1,264 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹130 Cr.